GEHCGE HealthCare
Is the business good?
The checks split: nothing decisive, though margins compressing.
Operating profit is falling even as sales grow, costs are outrunning the top line.
A balanced mix of margins, efficiency, and leverage. ROE 21% = margin × turnover × leverage.
All from derived.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is GEHC?
GE HealthCare earns 11% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.
Return on invested capital · cost of capital 9.0% · 2.3 points above what the capital costs: growth creates value
- Operating margin
- 13%
Operating margin · Medical Devices median 2.1% · 12 months to Q1 2026
- Share count, year on year
- −0.44%
Share count, year on year · flat: no meaningful dilution
- R&D as % of revenue
- 6.0%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2021 | 16% |
| FY2022 | 14% |
| FY2023 | 12% |
| FY2024 | 13% |
| FY2025 | 13% |
Details›
- Gross margin12 months to Q1 2026
- 39%
- Operating margin12 months to Q1 2026
- 13%
- Net margin12 months to Q1 2026
- 9.1%
- R&D as % of revenue
- 6.0%
- Revenue, trailing twelve months
- $21.0B
- Net income, trailing twelve months
- $1.91B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 11%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Devices
The closest names by size in the same industry